In addition to a focus on well-established segments of the health care sector, we have dedicated substantial resources to the emerging digital health industry.
Research capabilities for
the Digital Health sector
Digital health represents a convergence of healthcare, technology and consumer approaches aimed at achieving better outcomes by reducing inefficiencies, improving success, reducing costs, increasing quality and personalizing medicine. Leading examples include telehealth, mobile health/wellness, online content, wearables, remote patient monitoring and digital medicine.
Digital medicine is a key focus area, representing software and other technology tools that provide actionable intelligence to create new therapies or build on existing therapeutics for improved clinical outcomes.
Our research analysts covering technology, retail and health care have come together to examine how this convergence will impact the investment landscape.
We also host a number of related conferences including MedTools Unlocked and FutureHealth.
Charles RhyeeManaging Director, Health Care - Healthcare Technology & Distribution646 562 1376
Doug SchenkelManaging Director, Health Care - Life Science & Diagnostic Tools617 946 3918
Bryan Bergin, CFADirector, Technology, Media and Telecom - IT & Business Services646 562 1369
John BlackledgeManaging Director, Technology, Media and Telecom - Internet646 562 1359
Joshua Jennings, MDManaging Director, Health Care - Medical Supplies & Devices646 562 1333
J. Derrick Wood, CFAManaging Director, Technology, Media and Telecom - Software415 646 7370
Rick WeissensteinManaging Director, Cowen Washington Research Group - Health Care Services & Pharmaceutical Policy202 868 5311
Investment Banking capabilities for
the Digital Health sector
The digital health banking team combines the global resources and full service product capabilities of a leading financial institution with the focus and commitment of a specialty investment banking firm. The team includes professionals with expertise in health care as well as in technology, media and telecom, bringing clients well-rounded advice on the proper positioning of their stories.
The team combines a global distribution network with the focused expertise of a growth-oriented capital-markets and M&A advisory practice. We work with clients across several product lines, including private equity placements, PIPEs, initial public offerings, follow-on offerings, registered directs, convertible securities, exchangeables and M&A transactions.
Jamie StreatorManaging Director, Health Care646 562 1148
Rob WeirManaging Director, Health Care415 646 7392
Head of Investment Banking
D 646 562 1288